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Abstract 
Background: Plasma concentrations of atrial natriuretic peptides are correlated with atrial pressures, as are left ventricular 
ejection fraction and left ventricular filling abnormalities. Aims: This study investigated the relation of atrial natriuretic 
peptides to both left ventricular systolic and diastolic function in heart failure. Methods: Plasma concentrations of atrial 
natriuretic peptide and N-terminal pro-atrial natriuretic peptide were measured in 63 patients with chronic heart failure and 
left ventricular systolic dysfunction. According to Doppler transmitral f ow measurements, 19patients had a restrictive and 44 
patients had a non-restrictive l ft ventricular filling pattern. Results: Plasma concentrations of atrial natriuretic peptide and 
N-terminal pro-atrial natriuretic peptide were higher in patients with a restrictive falling pattern than in patients with a 
non-restrictive filling pattern (197 vs. 75 pmol/l, P < 0.0001 and 1.14 vs. 0..45 nmol/1, P < 0.0001). In univariate analysis, atrial 
natriuretic peptide and N-terminal pro-atrial natriuretic peptide correlated with deceleration time, E /A  ratio and left 
ventricular ejection fraction. In multivariate analysis, both peptides appeared independently related to left ventricular ejection 
fraction and left ventricular filling pattern. Conclusion: In patients with chronic heart failure, atrial natriuretic peptides 
provide information on left ventricular systolic as well as diastolic function. © 1999 European Society of Cardiology. All 
rights reserved. 
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1. Introduction 
Atrial natriuretic peptide (ANP) and the N-termi- 
nal fragment of its prohormone (N-terminal proANP) 
are known to be released in response to atrial stretch 
and to be closely correlated with atrial pressures in 
patients with heart failure [1,2]. Moreover, plasma 
atrial natriuretic peptide concentrations have been 
shown to be increased in patients with left ventricular 
systolic dysfunction and to be related to severity of 
heart failure [3-5]. 
*Corresponding author. Tel.: +31 10 4633949; fax: +31 10 
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In addition to left ventricular systolic dysfunction, 
abnormalities of diastolic function are common in 
patients with heart failure. Impaired relaxation in the 
presence of normal filling pressures results in reduced 
early diastolic filling. A restrictive filling pattern, on 
the other hand, is characterized by a fast, but abruptly 
ending increase in early filling reflecting diminished 
ventricular compliance and is associated with in- 
creased filling pressures, more severe disease and a 
poor prognosis [6-9]. 
In patients with left ventricular systolic dysfunction, 
a relationship between restrictive left ventricular 
filling patterns and elevated natriuretic peptide con- 
centrations has been described [10]. However, whether 
this association resulted from the evident differences 
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in left ventricular ejection fraction remained unde- 
fined. A clear understanding of the determinants of 
atrial natriuretic peptide concentrations in patients 
with heart failure is important for a correct interpre- 
tation of these markers of severity of the disease. For 
that reason, we studied the direct relationship between 
plasma atrial natriuretic peptide concentrations and 
left ventricular systolic as well as diastolic function in 
patients with heart failure. 
2. Methods 
2.1. Study population 
Within the framework of a comprehensive out-pa- 
tient heart failure study protocol, 69 consecutive 
patients with chronic heart failure and left ventricular 
systolic dysfunction due to coronary artery disease or 
dilated cardiomyopathy underwent several non-inva- 
sive cardiovascular tests, among which echocardiogra- 
phy and blood sampling for measurement of plasma 
atrial natriuretic peptide concentrations. For the pre- 
sent study, only patients who were in sinus rhythm 
were eligible. The study population consisted of 63 
patients, 54 men and nine women, aged 61 + 9 years. 
Clinical characteristics are presented in Table 1. 
Echocardiography and blood sampling were per- 
formed on the same day in the late morning, 2-3 h 
after administration of heart failure medication, in 
Table 1 
Clinical characteristics for all patients and for patients with 
restrictive and non-restrictive l ft ventricular filling patterns 
All patients Non-restrictive Restrictive 
pattern pattern 
n 63 44 19 
Age (years) 61 + 10 62 + 8 58 + 13 
Gender (male) 54 (86%) 38 (86%) 16 (84%) 
Aetiology (CAD) 40 (63%) 27 (61%) 13 (68%) 
MR (> grade 2) 5 (8%) 3 (7%) 2 (10%) 
Heart rate (b.p,m.) 72 + 11 71 + 10 75 + 14 
LVEF (%) 32 + 7 33 + 6 30 + 7 
NYHA classification 1.9 + 0.6 1.8 ± 0.6 2.3 + 0.6* 
Medication 
ACE irthibitors 57 (91%) 40 (91%) 17 (90%) 
Diuretics 47 (75%) 29 (66%) 18 (95%)** 
Digoxin 31 (49%) 20 (46%) 11 (58%) 
Nitrates 20 (32%) 15 (34%) 5 (26%) 
Notes. Data are expressed as mean + S.D. or number (%). *P = 
0.003; **P= 0.02, patients with non-restrictive vs. restrictive left 
ventricular filling patterns. CAD, coronary artery disease; MR, 
mitral regurgitation; LVEF, left ventricular ejection fraction; 
NYHA, New York Heart Association; ACE, angiotensin converting 
enzyme. 
order to standardize for diurnal variations of mea- 
surement parameters. The investigation conforms with 
the principles outlined in the Declaration of Helsinki. 
2.').. Echocardiography 
Left ventricular ejection fraction was calculated 
from the apical four-chamber and long-axis views 
using a biplane disk-method [11]. Mean values were 
obtained by averaging three consecutive beats. Mitral 
regurgitation was identified using continuous wave 
Doppler echocardiography and graded on a scale of 
one to four [12]. Left ventricular inflow velocities 
were recorded from the apical four-chamber view 
using pulsed Doppler echocardiography with the sam- 
ple volume placed between the tips of the mitral 
leaflets. Doppler measurements were made by manual 
tracing of the outermost portion of the velocity con- 
tour using an off-line computer, a digitizing tablet and 
a dedicated software program [13]. Parameters of left 
ventricular filling included peak early (E) and peak 
atrial (A) filling velocities, the E /A  ratio and deceler- 
ation time of peak early filling to baseline. Mean 
values were obtained by averaging 10 consecutive 
beats. Heart rate was averaged from the same beats. 
Patients were classified as having a restrictive or a 
non-restrictive l ft ventricular filling pattern based on 
E /A  ratio and deceleration time: an E /A  ratio > 2 
was considered to be restrictive, whereas an E /A  
ratio < 1 was considered to be non-restrictive. In case 
the', E /A  ratio was between 1 and 2, a deceleration 
time of < 150 ms was considered to be restrictive and 
a deceleration time > 150 ms was considered to be 
non-restrictive [14,15]. 
2.3 Atrial natriuretic peptides 
Venous blood samples were drawn after 30 min of 
supine rest and collected in pre-chilled polystyrene 
tubes containing EDTA and aprotinine. The tubes 
were placed on ice and centrifuged within 30 min 
from sampling in a refrigerated centrifuge for 10 min 
at 3000 × g. Plasma was stored in polyethylene tubes 
at -70°C until analysed. All analyses took place in 
the Cardiovascular Research Laboratory, University 
Hospital Rotterdam, The Netherlands. Plasma con- 
centrations of ANP were determined with a commer- 
cially available radioimmunoassay kit (Nichols Insti- 
tute, Wijchen, The Netherlands) after extraction from 
pla,~ma. N-terminal proANP concentrations were 
measured directly in plasma using a commercially 
available radioimmunoassay kit from Biotop, Oulu, 
Finland [16]. 
2.4. Statistical analysis 
C, omparisons between patients with restrictive and 
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non-restrictive left ventricular filling patterns were 
made by unpaired t-tests for continuous data and X 2 
tests for categorical data. Univariate linear regression 
analysis was used to test the relation between atrial 
natriuretic peptide concentrations and deceleration 
time, E /A  ratio and left ventricular ejection fraction. 
Multivariate linear regression analysis was used to 
evaluate the relation of plasma ANP and N-terminal 
proANP concentrations to left ventricular filling pat- 
tern, left ventricular ejection fraction, New York 
Heart Association functional class, diuretic therapy, 
heart rate, age and an interaction term between left 
ventricular filling pattern and age. Because of their 
skewed distribution, the natural logarithmic trans- 
formed values of ANP and N-terminal proANP were 
used in the analyses. Data are described as mean + 
S.D. unless otherwise specified. All analyses were 
performed with SPSS for Windows (release 6.1). Sta- 
tistical significance was defined as P < 0.05. 
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3. Results 
3.1. Group characteristics 
According to transmitral flow parameters, 19 
patients had a restrictive left ventricular filling pat- 
tern, whereas 44 patients had a non-restrictive l ft 
ventricular filling pattern. Both groups were compara- 
ble as regards age, gender, aetiology of heart failure, 
heart rate, left ventricular ejection fraction, presence 
of more than mild mitral regurgitation (> grade 2) on 
echocardiography and use of angiotensin converting 
enzyme inhibitors, digoxin and nitrates. However, 
patients with a restrictive left ventricular filling pat- 
tern were more symptomatic and were using diuretics 
more frequently than patients with a non-restrictive 
pattern (Table 1). 
3.2. Univariate analysis 
Plasma concentrations of ANP and N-terminal 
proANP were higher in patients with a restrictive 
filling pattern compared to patients with a non-re- 
strictive filling pattern (Fig. 1). Median (and range) 
for ANP (pmol/1) in patients with a restrictive vs. 
patients with a non-restrictive pattern were 197 
(83-358) vs. 75 (16-197) (P<0.0001) and for N- 
terminal proANP (nmol/l) 1.14 (0.52-2.42) vs. 0.45 
(0.10-1.26) (P < 0.0001). For the whole group, ANP 
correlated well with N-terminal proANP ( r= 0.89, 
P < 0.0001). In univariate linear regression analysis, 
ANP correlated with deceleration time (r = -0.52, 
P < 0.0001) (Fig. 2A), E /A  ratio (r = 0.50, P < 0.0001) 
(Fig. 3A) and left ventricular ejection fraction (r = 
- 0.37, P = 0.003). Similarly, N-terminal proANP was 
related to deceleration time (r = -0.48, P = 0.0001) 
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Fig. 1. Plasma concentrations of (A) atrial natriuretic peptide 
(ANP) and (B) N-terminal proANP according to left ventricular 
filling patcern. 
(Fig. 2B), E /A  ratio (r = 0.48, P = 0.0001) (Fig. 3B) 
and left ventricular ejection fraction (r = -0.38, P = 
0.002). 
3.3. Multivariate analysis 
In order to evaluate the relationship between atrial 
natriuretic peptide concentrations, left ventricular 
filling pattern and left ventricular systolic function, 
separate: multivariate linear regression analyses were 
performed for each peptide. Since age influences atrial 
natriuretic peptide concentrations [17] as well left 
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Fig. 2. Correlation between plasma concentrations of (A) atrial natriuretic peptide (ANP) and (B) N-terminal proANP and deceleration time. 
ventricular filling [18], both age and an interaction 
term between age and left ventricular filling pattern 
(derived by multiplying age by filling pattern) were 
included in the analyses. The standardized regression 
coefficients (/3) and corresponding P values are pre- 
sented in Table 2. New York Heart Association func- 
tional class, use of diuretics and heart rate were 
included in the analyses, but appeared not to be 
related to ANP and N-terminal proANP concentra- 
tions. In addition to (restrictive) left ventricular filling 
pattern and left ventricular ejection fraction, age and 
the interaction term between age and filling pattern 
explained 57% (R 2= 0.57) of the variation in ANP 
and 58% of the variation in N-terminal proANP. The 
presence of a restrictive left ventricular filling pattern 
by itself accounted for 39% of the variation in ANP 
and 36% of the variation in N-terminal proANP. The 
linear regression models of the relation between left 
ventricular ejection fraction and plasma ANP and 
plasma N-terminal proANP for patients with and 
without a restrictive left ventrieular filling pattern 
graphically represent the contribution of the presence 
of a restrictive pattern to the plasma concentrations 
of atrial natriuretic peptides in patients with compa- 
rable left ventricular ejection fractions (Fig. 4). 
4. D iscuss ion  
The present study shows that, in patients with 
chronic heart failure, elevated plasma concentrations 
of atrial natriuretic peptides are related to impaired 
left ventricular systolic function as well as abnormal 
left ventricular filling. Severity of systolic dysfunction 
and left ventricular filling abnormalities are important 
clinical and prognostic parameters in patients with 
heart failure due to coronary artery disease or dilated 
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Fig. 3. Correlation between plasma concentrations of (A) atrial natriuretic peptide (ANP) and (B) N-terminal pr0ANP and E /A  ratio. 
cardiomyopathy [7-9,19-21]. In both cardiac dis- 
orders, impaired left ventricular systolic function leads 
to progressive l ft ventricular dilatation and increased 
filling pressures. The accompanying reduction in left 
ventricular compliance, which results in a restrictive 
pattern of left ventricular filling, is associated with 
elevated filling pressures as well [8,22]. Thus, the 
present finding that both left ventricular systolic im- 
pairment and abnormal left ventricular filling are 
related to plasma atrial natriuretic peptide concentra- 
tions can be explained by the fact that systolic as well 
as diastolic dysfunction lead to increased filling pres- 
sures, and, as atrial natriuretic peptides are known to 
be released in response to atrial stretch or pressure 
[1,2], to elevated plasma concentrations of atrial natri- 
uretic peptides. 
4.1. Prior studies 
In contrast with the present results, plasma ANP 
was shown to be related to systolic but not to diastolic 
function in patients 24 h after myocardial infarction 
[23]. Furthermore, in patients with untreated essential 
hypertension a relation between a decreased E/A  
ratio and elevated concentrations of ANP has been 
described [24], while in the present study higher ANP 
concentrations were found in patients with an in- 
creased E /A  ratio. As Doppler assessment of diastolic 
function is known to be dependent on systolic func- 
tion [25], the results in hypertensives can not be 
compared with those in patients with heart failure 
due to left ventricular systolic dysfunction, nor can 
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Table 2 
Relation between atrial natriuretic peptide concentrations and left 
ventricular filling pattern, left ventricular ejection fraction and age 
- -  multivariate analysis 
Variables ANT N-terminal proANP 
/3 P values /3 P values 
LV filling pattern 2.31 < 0.0001 2.00 0.0003 
(restrictive) 
Age (years) 0.51 0.0002 0.58 < 0.0001 
Age × LV filling - 1.69 0.002 - 1.38 0.008 
pattern 
LVEF (%) - 0.20 0.03 - 0.22 0.02 
Abbreviations: /3, standardized regression coefficient; ANP, atrial 
natriuretic peptide; N-terminal proANP, N-terminal pro-atrial na- 
triuretic peptide; LV, left ventricular; Age × LV filling pattern, 
interaction term between age and left ventricular filling pattern; 
LVEF, left ventricular ejection fraction. 
the results from our study be applied to patients with 
heart failure and normal systolic function. 
4.2. Study limitations 
Transmitral f ow velocities are known to be affected 
by multiple factors, including age [18], heart rate [6] 
and mitral regurgitation [26]. Since both patient groups 
were comparable for age, heart rate and presence of 
more than mild mitral regurgitation, these variables 
are not considered to have influenced our results. In 
conformance with other reports [7,8], patients with a 
restrictive filling pattern were more symptomatic and 
were using diuretics more frequently compared to 
patients with a non-restrictive pattern. However, these 
differences did not contribute to the outcome of 
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A.A.M. l~jbenga et al. /European Journal of Heart Failure 1 (1999) 51-58 57 
mult ivariate analysis. The definitions for restrictive 
and non-restrict ive filling patterns could be con- 
s idered as arbitrary. Nevertheless, atrial natr iuret ic 
pept ide concentrat ions did not only differ between 
patients with different filling patterns, but correlated 
with transmitral  E /A  rat io and decelerat ion t ime as 
well. Finally, the t ime of  the day that p lasma samples 
were taken in relat ion to the t ime of  drug administra- 
tion might have been a source of variat ion in ANP 
and N-terminal  p roANP concentrations. Since all sub- 
jects were investigated in the late morning, 2 -3  h 
after administrat ion of heart fai lure medication, it 
was assumed that this contr ibut ion can be considered 
negligible. 
4.3. Conclusion 
In pat ients with chronic heart  failure, elevated 
plasma concentrat ions of atrial natr iuret ic pept ides 
are related to left ventricular systolic dysfunction as 
well as left ventr icular filling abnormalit ies.  This indi- 
cates that atrial natr iuretic pept ides can provide in- 
format ion on left ventricular systolic as well as dias- 
tolic function and points towards the potential  value 
of determinat ion of p lasma atrial natr iuretic pept ides 
as a simple test for overall cardiac function in the 
assessment of patients with heart failure. 
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